MAPK1 and RASopathy: In these studies, we generated the first genetically engineered mouse model of MAPK1-related Rasopathy (Mapk1A172V/+ mice), which recapitulates several clinical features observed in MRR patients: small stature, craniofacial dysmorphism, and cognitive impairment.